Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMC 422366)

Published in Infect Immun on March 01, 1972

Authors

J W Smith, S P Lowry, J L Melnick, W E Rawls

Articles cited by this

Preparation of a semipermanent mounting medium for fluorescent antibody studies. Virology (1960) 7.59

Localization of mouse isoantigens on the cell surface as revealed by immunofluorescence. Immunology (1967) 5.10

Biological markers for differentiation of herpes-virus strains of oral and genital origin. J Gen Virol (1969) 3.32

Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med (1968) 3.01

Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol (1970) 2.45

Herpesvirus antigens on cell membranes detected by centrifugation of membrane-antibody complexes. Science (1971) 2.19

The association of genital herpesvirus with cervical atypia and carcinoma in situ. Am J Epidemiol (1970) 2.17

Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. Am J Epidemiol (1970) 2.15

Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer (1969) 2.10

Differentiation between type 1 and type 2 strains of herpes simplex virus by an indirect immunofluorescent technique. J Gen Virol (1971) 2.03

NEW SURFACE ANTIGEN IN CELLS TRANSFORMED BY SIMIAN PAPOVAVIRUS SV40. Proc Soc Exp Biol Med (1965) 1.73

Investigation of plaque formation in chick embryo cells as a biological marker for distinguishing herpes virus type 2 from type 1. J Gen Virol (1971) 1.42

A specific surface antigen induced by poxvirus. Virology (1969) 1.38

Herpesvirus-type-2 antibodies and carcinoma of the cervix. Lancet (1970) 1.35

Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma. Proc Natl Acad Sci U S A (1970) 1.25

Surface antigen on chick kidney cells infected with the herpesvirus of Marek's disease. Virology (1970) 1.21

Reaction of serum from pregnant hamsters with surface of cells transformed by SV40. J Immunol (1970) 1.12

Serologic classification of Herpes simplex viruses. J Immunol (1971) 1.08

Immunological studies on Burkitt's lymphoma. Postgrad Med J (1971) 1.04

Use of immunofluorescence for detection of specific membrane antigen in simian virus 40-infected nontransformed cells. J Natl Cancer Inst (1967) 0.97

Characterization of the abortive infection of chick embryo cells by herpesvirus type I. J Gen Virol (1971) 0.97

Studies on the relation of membrane immunofluorescence to Epstein-Barr virus infection. J Natl Cancer Inst (1970) 0.94

Specific surface antigen in Shope papilloma cells. Virology (1969) 0.87

Cell surface antigen induced by venezuelan equine encephalomyelitis virus. Infect Immun (1970) 0.85

Herpesvirus and other factors related to the genesis of cervical cancer. Clin Obstet Gynecol (1970) 0.80

Articles by these authors

Enterovirus concentration on cellulose membranes. Appl Microbiol (1972) 11.78

Concentration of enteroviruses from large volumes of water. Appl Microbiol (1973) 11.43

Concentration of enteroviruses on membrane filters. J Virol (1967) 9.95

Concentration of viruses from sewage by adsorption on millipore membranes. Bull World Health Organ (1967) 7.73

Concentration of viruses from large volumes of tap water using pleated membrane filters. Appl Environ Microbiol (1976) 6.36

Extended use of nursing services in general practice. Br Med J (1967) 6.35

Concentration and purification of viruses by adsorption to and elution from insoluble polyelectrolytes. Appl Microbiol (1971) 5.71

The practice nurse--a new look. Br Med J (1970) 5.16

Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med (1966) 5.11

Ligand binding to integrins. J Biol Chem (2000) 4.94

Rapid isolation of bacteria from septicemic patients by use of an antimicrobial agent removal device. J Clin Microbiol (1980) 4.52

Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull World Health Organ (1973) 4.27

Virus aggregation as the cause of the non-neutralizable persistent fraction. J Virol (1967) 4.25

Preparation of antiserum to enteroviruses in large animals. J Immunol (1965) 4.20

Concentration of viruses on aluminum and calcium salts. Am J Epidemiol (1967) 4.19

Concentration of viruses from sewage and excreta on insoluble polyelectrolytes. Appl Microbiol (1969) 4.17

Concentration of enteroviruses from large volumes of tap water, treated sewage, and seawater. Appl Environ Microbiol (1978) 4.01

Virus movement in soil columns flooded with secondary sewage effluent. Appl Environ Microbiol (1976) 3.99

THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. III. PERSISTENCE OF VIRUS IN STOOLS AFTER ACUTE INFECTION. J Clin Invest (1946) 3.88

THE DETECTION OF POLIOMYELITIS VIRUS IN FLIES. Science (1941) 3.81

A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80

Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol (1987) 3.70

Structure and Composition of a Small Particle Prepared from a Simian Adenovirus. J Bacteriol (1965) 3.54

A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34

Reactions to tetanus toxoid. J Hyg (Lond) (1973) 3.33

Biological markers for differentiation of herpes-virus strains of oral and genital origin. J Gen Virol (1969) 3.32

Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol (1968) 3.29

Virus isolations from sewage and from a stream receiving effluents of sewage treatment plants. Bull World Health Organ (1970) 3.27

THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. IV. SEARCH FOR VIRUS IN THE BLOOD OF PATIENTS. J Clin Invest (1946) 3.25

Physical assay and growth cycle studies of a defective adeno-satellite virus. J Virol (1967) 3.15

Virus and bacteria removal from wastewater by land treatment. Appl Environ Microbiol (1976) 3.10

Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07

Environmental factors influencing isolation of enteroviruses from polluted surface waters. Appl Microbiol (1974) 3.06

POLIOMYELITIS VIRUS IN FLY-CONTAMINATED FOOD COLLECTED AT AN EPIDEMIC. Science (1945) 3.04

Herpesvirus type 2: association with carcinoma of the cervix. Science (1968) 3.03

Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun (1982) 3.02

Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01

Role of sediment in the persistence of enteroviruses in the estuarine environment. Appl Environ Microbiol (1978) 2.99

A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol (1968) 2.92

WHO collaborative studies on enterovirus reference antisera. Bull World Health Organ (1965) 2.82

Plus and minus single-stranded DNA separately encapsidated in adeno-associated satellite virions. Science (1969) 2.76

The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol (1969) 2.74

Local immune response in experimental pyelonephritis. J Clin Invest (1969) 2.73

Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation (1996) 2.64

Localization of urinary-tract infections by detection of antibody-coated bacteria in urine sediment. N Engl J Med (1974) 2.63

Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63

Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61

Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61

Type C viruses of baboons: isolation from normal cell cultures. Cell (1974) 2.55

Colorimetric method for rapid determination of bacteriuria. J Clin Microbiol (1981) 2.51

Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol (1970) 2.45

Enzyme induction in SV40-infected green monkey kidney cultures. Virology (1966) 2.45

Small deoxyribonucleic acid-containing viruses (picodnavirus group). Nature (1966) 2.45

Enhanced detection of Australia antigen in serum hepatitis patients by discontinuous counter-immunoelectrophoresis. Appl Microbiol (1971) 2.44

Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42

Wastewater renovation and reuse: virus removal by soil filtration. Science (1976) 2.37

Effects of pancreatin on the growth of reovirus. J Bacteriol (1966) 2.35

Development of a quantitative method for detecting enteroviruses in estuarine sediments. Appl Environ Microbiol (1977) 2.35

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS) JAMA (2000) 2.33

Detection of hepatitis A viral antigen by radioimmunoassay. J Immunol (1975) 2.33

Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization. Vaccine (1993) 2.30

Enterovirus type 70: the etiologic agent of pandemic acute haemorrhagic conjunctivitis. Bull World Health Organ (1973) 2.29

SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27

Occurrence and distribution of bacterial indicators and pathogens in canal communities along the Texas coast. Appl Environ Microbiol (1977) 2.26

Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies. J Virol (1982) 2.24

RED: a red-cell antibody identification expert module. J Med Syst (1985) 2.24

Concentration of enteroviruses from estuarine water. Appl Environ Microbiol (1977) 2.22

General practitioners in hospital. Br Med J (1970) 2.22

New rat model of Pneumocystis carinii infection. J Clin Microbiol (1988) 2.21

Concentration and purification of influenza virus on insoluble polyelectrolytes. Appl Microbiol (1972) 2.20

Excess mortality associated with influenza in England and Wales. Int J Epidemiol (1977) 2.20

Human enteroviruses in oysters and their overlying waters. Appl Environ Microbiol (1979) 2.20

Viral hepatitis. Clinical and tissue culture studies. JAMA (1970) 2.20

Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19

WHO collaborative study on the sero-epidemiology of rubella. Bull World Health Organ (1967) 2.17

Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17

Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Clin Microbiol (1994) 2.17

WHO collaborative studies on enterovirus reference antisera. Third report. Bull World Health Organ (1970) 2.15

Environmental virology: from detection of virus in sewage and water by isolation to identification by molecular biology--a trip of over 50 years. Annu Rev Microbiol (1995) 2.13

Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet (1983) 2.13

MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res (2001) 2.12

Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol (1983) 2.12

Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11

Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid. J Virol (1967) 2.10

Viruses in water. Bull World Health Organ (1978) 2.10

Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis (1984) 2.09

Nucleotide sequence variation in Pneumocystis carinii strains that infect humans. J Clin Microbiol (1993) 2.08

Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol (1995) 2.07

The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol (1990) 2.07

Reconcentration of poliovirus from sewage. Appl Environ Microbiol (1976) 2.05

Duration of immunity after active immunisation against tetanus. Lancet (1969) 2.04

Selective assay for herpes simplex viruses expressing thymidine kinase. J Virol (1979) 2.03

Mechanism of enhancement of virus plaques by cationic polymers. J Virol (1968) 2.02